Mirum Pharmaceuticals, Inc. (MIRM)
92.29
+0.10
(+0.11%)
USD |
NASDAQ |
Feb 27, 16:00
92.24
-0.05
(-0.05%)
After-Hours: 20:00
Mirum Pharmaceuticals Research and Development Expense (TTM) : 185.83M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 771.09M |
| BridgeBio Pharma, Inc. | 451.95M |
| XOMA Royalty Corp. | 2.295M |
| CorMedix, Inc. | 12.46M |
| ADMA Biologics, Inc. | 4.761M |